Skip to main content

Cellular engineering for the treatment of metabolic disorders: prospects for therapy in diabetes.

Publication ,  Journal Article
Newgard, CB
Published in: Biotechnology (N Y)
October 1992

Significant advances in the areas of identification of disease susceptibility genes and gene transfer technologies have fueled new initiatives in cellular engineering as a means for treating metabolic disease. This article utilizes new findings from such work as the blueprint for a discussion of the prospects for gene therapy in diabetes mellitus.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Biotechnology (N Y)

DOI

ISSN

0733-222X

Publication Date

October 1992

Volume

10

Issue

10

Start / End Page

1112 / 1120

Location

United States

Related Subject Headings

  • Transfection
  • Rats
  • Mice
  • Insulinoma
  • Insulin Resistance
  • Insulin Infusion Systems
  • Humans
  • Glucose
  • Genetic Therapy
  • Diabetes Mellitus, Type 2
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Newgard, C. B. (1992). Cellular engineering for the treatment of metabolic disorders: prospects for therapy in diabetes. Biotechnology (N Y), 10(10), 1112–1120. https://doi.org/10.1038/nbt1092-1112
Newgard, C. B. “Cellular engineering for the treatment of metabolic disorders: prospects for therapy in diabetes.Biotechnology (N Y) 10, no. 10 (October 1992): 1112–20. https://doi.org/10.1038/nbt1092-1112.
Newgard, C. B. “Cellular engineering for the treatment of metabolic disorders: prospects for therapy in diabetes.Biotechnology (N Y), vol. 10, no. 10, Oct. 1992, pp. 1112–20. Pubmed, doi:10.1038/nbt1092-1112.

Published In

Biotechnology (N Y)

DOI

ISSN

0733-222X

Publication Date

October 1992

Volume

10

Issue

10

Start / End Page

1112 / 1120

Location

United States

Related Subject Headings

  • Transfection
  • Rats
  • Mice
  • Insulinoma
  • Insulin Resistance
  • Insulin Infusion Systems
  • Humans
  • Glucose
  • Genetic Therapy
  • Diabetes Mellitus, Type 2